Clinical Trial Update: Safety Study of Tuberculosis Vaccines AERAS-402 and MVA85A [Phase 1]

View source ↗

Summary

Phase 1 safety study of tuberculosis vaccines AERAS-402 and MVA85A has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tuberculosis

Drugs mentioned

• AERAS-402
• MVA85A (Modified Vaccinia Ankara expressing antigen 85A)

Snippet

Sponsor: University of Oxford | Conditions: Tuberculosis | Phase 1 | Status: COMPLETED